Gutgermina Oral Suspension contains Bacillus clausii spores (2 billion per dose), a probiotic formulation designed to restore and maintain the natural balance of intestinal microflora. This suspension is indicated for the prevention and treatment of dysbiosis associated with antibiotic therapy, gastrointestinal infections, and other conditions leading to an imbalance of gut bacteria. Bacillus clausii is a non-pathogenic, spore-forming bacterium that survives gastric acidity and colonizes the intestinal tract, where it exerts beneficial effects by inhibiting the growth of pathogenic microorganisms and promoting the regeneration of the intestinal mucosa. Gutgermina Oral Suspension is particularly useful in managing antibiotic-associated diarrhea, traveler’s diarrhea, and other forms of acute or chronic diarrhea. The product is administered orally, with the recommended dosage varying according to the patient’s age and clinical condition. It is generally well tolerated, with minimal adverse effects reported. Use in immunocompromised patients should be approached with caution. Gutgermina Oral Suspension is a valuable adjunct in gastrointestinal health management, supporting the restoration of a healthy gut microbiome and improving digestive function during and after disturbances caused by infections or pharmacological interventions.